TRADING UPDATES: Beximco suspension lifted; M1 payment date extension
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Friday and not separately reported by Alliance News: Read More
| Price | 58.50p on 16-09-2026 at 18:35:09 |
|---|---|
| Change | 0.00p 0% |
| Buy | 62.00p |
| Sell | 55.00p |
| Last Trade: | Buy 14.00 at 61.80p |
| Day's Volume: | 23,494 |
| Last Close: | 58.50p |
| Open: | 58.50p |
| ISIN: | US0885792061 |
| Day's Range | 58.50p - 58.50p |
| 52wk Range: | 35.00p - 64.00p |
| Market Capitalisation: | £260.98m |
| VWAP: | 60.68763p |
| Shares in Issue: | 446.11m |
Sector: Medicine and Biotech
Beximco Pharma (BXP) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 14 | 61.80p | Ordinary |
16:28:11 - 16-Sep-26 |
| Unknown* | 20,480 | 61.00p | Ordinary |
16:18:14 - 16-Sep-26 |
| Buy* | 3,000 | 58.55p | Ordinary |
16:02:14 - 16-Sep-26 |
| Buy* | 5,000 | 60.00p | Ordinary |
14:49:19 - 15-Sep-26 |
| Buy* | 5,000 | 60.00p | Ordinary |
14:43:35 - 15-Sep-26 |
| Sell* | 2,000 | 60.65p | Ordinary |
16:08:50 - 14-Sep-26 |
| Sell* | 12 | 60.00p | Ordinary |
15:05:56 - 11-Sep-26 |
| Sell* | 1,274 | 62.45p | Ordinary |
10:30:15 - 11-Sep-26 |
| Sell* | 2,000 | 62.45p | Ordinary |
10:25:13 - 11-Sep-26 |
| Sell* | 8,000 | 62.45p | Ordinary |
09:24:02 - 11-Sep-26 |
Beximco Pharma (BXP) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 15th Sep 2026 11:47 am | RNS | Clarification of Press Commentary |
| 26th Jun 2026 7:30 am | RNS | Restoration - Beximco Pharmaceuticals PLC |
| 26th Jun 2026 7:00 am | RNS | Results for the year ended 30 June 2025 |
| 24th Jun 2026 7:05 am | RNS | Notification of Preliminary Results and AGM |
| 24th Jun 2026 7:04 am | RNS | Q3 Financial Results 2025-26 |
| 24th Jun 2026 7:03 am | RNS | Half Year Results 2025-26 |
| 24th Jun 2026 7:02 am | RNS | Q1 Financial Results 2025-26 |
| 24th Jun 2026 7:01 am | RNS | Q3 Financial Results 2024-25 |
| 24th Jun 2026 7:00 am | RNS | Financial Results from 1 Jan 25 to 31 Mar 26 |
| 22nd Jun 2026 11:04 am | RNS-R | First patients access affordable CF medicine |